-
1دورية أكاديمية
المؤلفون: Ortega-Deballon, Pablo, Glehen, Olivier, Levine, Edward, Piso, Pompiliu, Sugarbaker, Paul, H., Hayes-Jordan, Andrea, Facy, Audrey, Bakrin, Naoual, Rat, Patrick
المساهمون: Lipides - Nutrition - Cancer (U866) (LNC), Université de Bourgogne (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Ecole Nationale Supérieure de Biologie Appliquée à la Nutrition et à l'Alimentation de Dijon (ENSBANA), Département de chirurgie thoracique et digestive CHU de Dijon, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Centre Hospitalier Lyon Sud CHU - HCL (CHLS), Hospices Civils de Lyon (HCL), Baptist Medical Center, Wake Forest University, University Medical Center of Regensburg, Washington Cancer Institute, MD Anderson Cancer Center, The University of Texas M.D. Anderson Cancer Center Houston, This work was supported by a grant from the University Hospital of Dijon and the Regional Council of Burgundy 2009.
المصدر: ISSN: 1068-9265.
مصطلحات موضوعية: pregnancy, childbearing, peritoneal carcinomatosis, pseudomyxoma, HIPEC, intraperitoneal chemotherapy, mesothelioma, MESH: Adolescent, MESH: Adult, MESH: Young Adult, MESH: Antineoplastic Combined Chemotherapy Protocols, MESH: Chemotherapy, Cancer, Regional Perfusion, MESH: Cisplatin, MESH: Combined Modality Therapy, MESH: Female, MESH: Follow-Up Studies, MESH: Humans, MESH: Hyperthermia, Induced, MESH: International Agencies, MESH: Mitomycin, MESH: Peritoneal Neoplasms, MESH: Pregnancy, MESH: Pregnancy Complications, Neoplastic, MESH: Questionnaires, MESH: Survival Rate, MESH: Treatment Outcome
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/21311981; inserm-00567418; https://inserm.hal.science/inserm-00567418Test; https://inserm.hal.science/inserm-00567418/documentTest; https://inserm.hal.science/inserm-00567418/file/baby_HIPEC_manuscript_authors.pdfTest; https://inserm.hal.science/inserm-00567418/file/inserm-00567418_edited.pdfTest; https://inserm.hal.science/inserm-00567418/file/Table_1.pdfTest; https://inserm.hal.science/inserm-00567418/file/Table_2.pdfTest; https://inserm.hal.science/inserm-00567418/file/Table_3.pdfTest; PUBMED: 21311981; PUBMEDCENTRAL: PMC3504463
الإتاحة: https://doi.org/10.1245/s10434-011-1595-5Test
https://inserm.hal.science/inserm-00567418Test
https://inserm.hal.science/inserm-00567418/documentTest
https://inserm.hal.science/inserm-00567418/file/baby_HIPEC_manuscript_authors.pdfTest
https://inserm.hal.science/inserm-00567418/file/inserm-00567418_edited.pdfTest
https://inserm.hal.science/inserm-00567418/file/Table_1.pdfTest
https://inserm.hal.science/inserm-00567418/file/Table_2.pdfTest
https://inserm.hal.science/inserm-00567418/file/Table_3.pdfTest -
2
المؤلفون: Ortega-Deballon , Pablo, Glehen , Olivier, Levine , Edward, Piso , Pompiliu, Sugarbaker , Paul, Hayes-Jordan , Andrea, Facy , Audrey, Bakrin , Naoual, Rat , Patrick
المساهمون: Lipides - Nutrition - Cancer (U866) ( LNC ), Université de Bourgogne ( UB ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Ecole Nationale Supérieure de Biologie Appliquée à la Nutrition et à l'Alimentation de Dijon ( ENSBANA ), Département de chirurgie thoracique et digestive [CHU de Dijon], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand ( CHU Dijon ), Centre Hospitalier Lyon Sud [CHU - HCL] ( CHLS ), Hospices Civils de Lyon ( HCL ), Baptist Medical Center, Wake Forest University, University Medical Center of Regensburg, Washington Cancer Institute, MD Anderson Cancer Center, This work was supported by a grant from the University Hospital of Dijon and the Regional Council of Burgundy 2009.
المصدر: Annals of Surgical Oncology
Annals of Surgical Oncology, Springer Verlag, 2011, 18 (8), pp.2297-301. 〈10.1245/s10434-011-1595-5〉مصطلحات موضوعية: MESH : Mitomycin, MESH : Hyperthermia, Induced, MESH : Antineoplastic Combined Chemotherapy Protocols, MESH : International Agencies, MESH : Young Adult, MESH : Treatment Outcome, pseudomyxoma, intraperitoneal chemotherapy, MESH : Cisplatin, MESH : Peritoneal Neoplasms, MESH : Adolescent, MESH : Pregnancy Complications, Neoplastic, MESH : Female, [ SDV.MHEP.CHI ] Life Sciences [q-bio]/Human health and pathology/Surgery, HIPEC, MESH : Humans, peritoneal carcinomatosis, MESH : Questionnaires, MESH : Follow-Up Studies, MESH : Chemotherapy, Cancer, Regional Perfusion, MESH : Adult, MESH : Survival Rate, childbearing, MESH : Pregnancy, mesothelioma, pregnancy, MESH : Combined Modality Therapy
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4f1ce4f4180859cdbdd1a25b1b7101bdTest
http://www.hal.inserm.fr/inserm-00567418Test